SciGuy: Refinancing the Future

Anonymous

Guest
So the February 2015 assumption of $2.2B new debt may have been to allow early retirement of outstanding (higher interest rate) debt? Is this normal financial management? Or the smell of smoke? I try to avoid using one credit card to pay off another.

Lilly Announces Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities and the Redemption of Its 6.57% Notes due 2016

DEFINITION of 'Debt Tender Offer'

When a firm retires all or a portion of its debt securities by making an offer to its debtholders to repurchase a predetermined number of bonds at a specified price and during a set period of time. Firms may use a debt tender offer as a mechanism for capital restructuring or refinancing.

INVESTOPEDIA EXPLAINS 'Debt Tender Offer'

For example, a firm may have issued bonds during a time when interest rates were high. If interest rates have come down significantly, the firm may want to conduct a new bond offering at a lower rate and then use the proceeds to conduct a debt tender offering in order to buy back the more expensive bonds as a way of cutting costs.

Furthermore, a highly leveraged firm may also wish to use its retained earnings to buy back bonds in order lower its debt-to-equity ratio. Doing so will give the company a greater margin of safety against bankruptcy because the company will be paying less interest.
 












Lillly with no new products and definitely no cash cows at this time must play money games to keep Wall Street happy. No R&D to speak of just new investments e.g. BioNtech GmbH.

An article which begins: "Eli Lilly and German Startup Collaborating on Cancer Immunotherapies" ends with the following:

"Eli Lilly, based in Indianapolis, is among the largest companies of its kind in the world."

And what exactly is "...its kind..." ??
 




An article which begins: "Eli Lilly and German Startup Collaborating on Cancer Immunotherapies" ends with the following:

"Eli Lilly, based in Indianapolis, is among the largest companies of its kind in the world."

And what exactly is "...its kind..." ??

That's like. "Eli Lilly is an employer of people"

...that was a good one....... a couple reallocations ago
 








The guy (John Caroll) that wrote that article is bought and paid for. All of his articles are unrealistic about Lilly.

It was also our defense in the Zyprexa 5 at 5 off-label case. If we were not a major employer, we would have been convicted of a felony.

Every time we have a reallocation, our chances of a narrow escape from more trouble get reduced just as much.

Something to think about bean counters.